Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
We review extensive progress from the cancer metabolism community in understanding the specific properties of lipid metabolism as it is redesigned in advanced carcinomas. This redesigned lipid metabolism allows affected carcinomas to make enhanced catabolic use of lipids in ways that are regulated b...
Main Authors: | Paul M. Bingham, Zuzana Zachar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/18/14365 |
Similar Items
-
CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
by: Lixia Gao, et al.
Published: (2020-04-01) -
Synthesis of both enantiomers and the 13C derivative of CPI-2850, the major metabolite of Devimistat
by: Poli Adi Narayana Reddy, et al.
Published: (2022-01-01) -
Inhibition of Mitochondrial Metabolism Leads to Selective Eradication of Cells Adapted to Acidic Microenvironment
by: Martina Koncošová, et al.
Published: (2021-10-01) -
Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
by: Liwei Lang, et al.
Published: (2021-12-01) -
Smart Design of Mitochondria-Targeted and ROS-Responsive CPI-613 Delivery Nanoplatform for Bioenergetic Pancreatic Cancer Therapy
by: Yi-Mei Zhang, et al.
Published: (2021-10-01)